Oral contraceptives and intrahepatic biliary cystadenoma having an increased level of estrogen receptor.

Abstract

We report a case of intrahepatic biliary cystadenoma in a young woman who had no prior history of liver disease and who had taken oral contraceptives for one year. A 27-year-old woman was admitted to our hospital with a firm epigastric mass. At laparotomy, a large cystic mass was resected from the left hepatic lobe, and diagnosed as biliary cystadenoma. In the tumor tissue, the estrogen receptor content was 14.0 fmol/mg cytosol protein, which was much higher than the 3.0 fmol/mg cytosol protein in the surrounding liver tissue. This is the first case of biliary cystadenoma in which the estrogen receptor content was increased.

• Authors: Y Suyama, Y Horie, T Suou, C Hirayama, M Ishiguro, O Nishimura, S Koga
• Journal: Hepato-gastroenterology (Hepatogastroenterology) Vol. 35 Issue 4 Pg. 171-4 (Aug 1988) ISSN: 0172-6390 [Print] Greece
• PMID: 3181863 (Publication Type: Case Reports, Journal Article)

Chemical References

• Contraceptives, Oral, Combined
• Receptors, Estrogen
• Mestranol
• Lynestrenol

Topics

• Adult
• Bile Duct Neoplasms (analysis, chemically induced)
• Bile Ducts, Intrahepatic (pathology)
• Contraceptives, Oral, Combined (adverse effects)
• Cystadenoma (analysis, chemically induced)
• Female
• Humans
• Lynestrenol
• Mestranol
• Receptors, Estrogen (analysis)